Publications
- SGLT2 inhibitors and atherosclerosis in a background of effect of gliflozins and heart failure2021 | First Faculty of Medicine
- News in the treatment of heart failure - gliflozins in patients with a mildly reduced and preserved ejection fraction2023 | First Faculty of Medicine
- Chronic cardiorenal syndrome and gliflozins - a cardiologist's view2023 | First Faculty of Medicine
- Glifloziny v léčbě srdečního selhání: aktuality a perspektivy2022 | First Faculty of Medicine
- Immuno-thrombosis, coagulopathy, pulmonary embolism and diagnosis in patients with COVID-192022 | First Faculty of Medicine
- Diagnostic methods in cardiovascular diseases2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- SGLT2 inhibitory v primární prevenci u pacientů s diabetem 2. typu2020 | First Faculty of Medicine
- Mechanismy kardioprotektivních a nefroprotektivních účinků inhibitorů SGLT2 nejen u pacientů s diabetem 2. typu2020 | First Faculty of Medicine
- Heart failure in patients with diabetes - treatment and prevention2019 | First Faculty of Medicine
- Riziko hospitalizace pro srdeční selhání u diabetiků 2. typu v závislosti na věku, kompenzaci glykemie a přítomnosti albuminurie2019 | First Faculty of Medicine
Loading network view...